Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Neuropathy: early-phase trial registry
1 of 9 indexed Diabetic Neuropathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 1 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Diabetic Neuropathy: 9 US clinical trials tracked, 1 recruiting.
Diabetic Neuropathy is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Avanir Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition diabetic-neuropathy
OPEN 1 | RECR 11% | LATE 2 | EARLY 4 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Alcohol Use Disorders (11% recruiting · 9 trials)
Diabetic Neuropathy lists 1 open slots (11% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Neuropathy is recruiting below its size-band peers.
1 of 9 indexed trials (11.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Diabetic Neuropathy trials is spread across many organizations.
Avanir Pharmaceuticals accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetic Neuropathy enrolment sits around 128 participants.
Median target enrolment is 128 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.
-
Diabetic Neuropathy research is mostly interventional.
8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks
Endocrine Research Solutions
NCT06452914
Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project
CND Life Sciences
NCT07005947
Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy
Avanir Pharmaceuticals
NCT00113620
Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy
Quigley Pharma
NCT00568035
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
BioDelivery Sciences International
NCT02643251
Study of DA-9801 to Treat Diabetic Neuropathy
NeuroBo Pharmaceuticals
NCT01822925
Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training
Click Therapeutics
NCT05573685
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Endo Pharmaceuticals
NCT00904202
The Effect of Ruboxistaurin on Small Fiber Function
Chromaderm
NCT00190970
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Neuropathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Neuropathy page
9 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Diabetic Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Avanir Pharmaceuticals sponsors the most Diabetic Neuropathy trials on record, review their full trial history before evaluating a specific study. See Avanir Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Neuropathy condition card totals 9 registered trials; most-linked intervention Neurodex; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.